Sign in
4/A

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-010143

Options or other derivatives

  • CEO and President acquired 111,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Shefferman Jesse CEO and President 2020-01-10 Grant or award · Stock Option (Right to Buy) +111,250 111,250 D
Loading xslF345X03/doc4a.xml…